219 related articles for article (PubMed ID: 15238875)
1. Does atazanavir cause lipodystrophy?
Gazzard BG; Moyle G
J HIV Ther; 2004 May; 9(2):41-4. PubMed ID: 15238875
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results.
Gatell J; Salmon-Ceron D; Lazzarin A; Van Wijngaerden E; Antunes F; Leen C; Horban A; Wirtz V; Odeshoo L; Van den Dungen M; Gruber C; Ledesma E;
Clin Infect Dis; 2007 Jun; 44(11):1484-92. PubMed ID: 17479947
[TBL] [Abstract][Full Text] [Related]
3. Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.
Nguyen ST; Eaton SA; Bain AM; Rahman AP; Payne KD; Bedimo R; Herrington JD; Maclayton DO; Rodriguez-Barradas MC; Busti AJ
Pharmacotherapy; 2008 Mar; 28(3):323-30. PubMed ID: 18294112
[TBL] [Abstract][Full Text] [Related]
4. Electrocardiographic changes in HIV-infected, drug-experienced patients being treated with atazanavir.
Gianotti N; Guffanti M; Galli L; Margonato A; Chiaravalli G; Bigoloni A; Lazzarin A; Castagna A
AIDS; 2007 Jul; 21(12):1648-51. PubMed ID: 17630564
[TBL] [Abstract][Full Text] [Related]
5. Can boosted atazanavir induce hyperlipotrophy?
Dellamonica P
J Infect; 2006 Jun; 52(6):e189-90. PubMed ID: 16239035
[TBL] [Abstract][Full Text] [Related]
6. [Lipid profile of atazanavir].
Martínez Chamorro E
Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():34-40. PubMed ID: 20116615
[TBL] [Abstract][Full Text] [Related]
7. Urolithiasis in HIV-positive patients treated with atazanavir.
Couzigou C; Daudon M; Meynard JL; Borsa-Lebas F; Higueret D; Escaut L; Zucman D; Liotier JY; Quencez JL; Asselah K; May T; Neau D; Vittecoq D
Clin Infect Dis; 2007 Oct; 45(8):e105-8. PubMed ID: 17879904
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.
Landman R; Capitant C; Descamps D; Chazallon C; Peytavin G; Katlama C; Pialoux G; Bentata M; Brun-Vézinet F; Aboulker JP; Yéni P;
J Antimicrob Chemother; 2009 Jul; 64(1):118-25. PubMed ID: 19420019
[TBL] [Abstract][Full Text] [Related]
9. Metabolic disorders and cardiovascular risk in HIV-infected patients treated with antiretroviral agents.
Fantoni M; Del Borgo C; Autore C; Barbaro G
Ital Heart J; 2002 May; 3(5):294-9. PubMed ID: 12066561
[TBL] [Abstract][Full Text] [Related]
10. [Utility of atazanavir in special populations].
Antela López A
Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():49-54. PubMed ID: 20116618
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial.
Soriano V; García-Gasco P; Vispo E; Ruiz-Sancho A; Blanco F; Martín-Carbonero L; Rodríguez-Novoa S; Morello J; de Mendoza C; Rivas P; Barreiro P; González-Lahoz J
J Antimicrob Chemother; 2008 Jan; 61(1):200-5. PubMed ID: 17999977
[TBL] [Abstract][Full Text] [Related]
12. Atazanavir urolithiasis.
Chang HR; Pella PM
N Engl J Med; 2006 Nov; 355(20):2158-9. PubMed ID: 17108352
[No Abstract] [Full Text] [Related]
13. Revised package insert for atazanavir.
Sax PE
AIDS Clin Care; 2008 Mar; 20(3):23. PubMed ID: 18399014
[No Abstract] [Full Text] [Related]
14. Anti-HIV agents. Atazanavir and saquinavir.
TreatmentUpdate; 2004; 16(3):9-10. PubMed ID: 17219610
[No Abstract] [Full Text] [Related]
15. Anti-HIV agents. Atazanavir and raltegravir--an interesting combination.
TreatmentUpdate; 2009; 21(3):3-4. PubMed ID: 19623725
[No Abstract] [Full Text] [Related]
16. Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
Ly T; Ruiz ME
Clin Infect Dis; 2007 Mar; 44(6):e67-8. PubMed ID: 17304444
[TBL] [Abstract][Full Text] [Related]
17. Drug interactions. Kaletra and atazanavir.
TreatmentUpdate; 2006; 18(3):7-8. PubMed ID: 17211919
[No Abstract] [Full Text] [Related]
18. Atazanavir in children.
Prescrire Int; 2011; 20(118):177. PubMed ID: 21751749
[No Abstract] [Full Text] [Related]
19. HIV therapeutics, continued: another HIV protease inhibitor approved.
Laurence J
AIDS Read; 2003 Aug; 13(8):355-6. PubMed ID: 14524318
[No Abstract] [Full Text] [Related]
20. FDA notifications. Atazanavir capsule label is updated for pediatric patients.
AIDS Alert; 2008 May; 23(5):59-60. PubMed ID: 18637262
[No Abstract] [Full Text] [Related]
[Next] [New Search]